Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly, prescribed at DermaVue clinics across Kerala and Tamil Nadu, India, for physician-supervised medical weight loss
Winner: tirzepatide / Zepbound Round 3: Side Effects All GLP-1 medications have similar side effects
This one is more nuanced, but the short answer is yes, people with significant kidney or liver disease should be very cautious and likely avoid it
Manufactured in Scotts Valley, CA, under the Good Manufacturing Practices (cGMPs) established by the US Food and Drug Administration (FDA).
This excess creates reductive stress, which eventually harms the heart's ability to pump
Heat application is known to reduce muscle spasms